Cargando…
Involvement of poly(ADP-ribose) polymerase-1 in development of spinal cord injury in Chinese individuals: a Chinese clinical study
OBJECTIVE: We aimed to evaluate whether the polymorphism of poly(ADP-ribose) polymerase-1 (PARP-1) is involved as potential risk factor in the development of spinal cord injury (SCI) among Chinese individuals. PATIENTS AND METHODS: Patients with a confirmed diagnosis of SCI (other than traumatic inj...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723107/ https://www.ncbi.nlm.nih.gov/pubmed/29255350 http://dx.doi.org/10.2147/DDDT.S142005 |
_version_ | 1783285150343233536 |
---|---|
author | Meng, Qing-Tao Yang, Guang Li, Ren-Bo Nie, Jing-Xin Zhou, Wei Yu, Hong-De Chen, Bo Jiang, Li Shang, Jing-Bo |
author_facet | Meng, Qing-Tao Yang, Guang Li, Ren-Bo Nie, Jing-Xin Zhou, Wei Yu, Hong-De Chen, Bo Jiang, Li Shang, Jing-Bo |
author_sort | Meng, Qing-Tao |
collection | PubMed |
description | OBJECTIVE: We aimed to evaluate whether the polymorphism of poly(ADP-ribose) polymerase-1 (PARP-1) is involved as potential risk factor in the development of spinal cord injury (SCI) among Chinese individuals. PATIENTS AND METHODS: Patients with a confirmed diagnosis of SCI (other than traumatic injury) and healthy individuals with no clinical symptoms of SCI were enrolled at Spinal Cord Injury Care Center, The Third People’s Hospital of Dalian, China. Genetic polymorphisms were studied in plasma samples by polymerase chain reaction-restriction fragment length polymorphism assay. RESULTS: A total of 130 Chinese patients with SCI and 130 healthy Chinese individuals were included. We found that patients with the GG genotype (odds ratio [OR]: 4.09, 95% confidence interval [CI] 2.42–6.90, P<0.001) and carriers of the G allele (OR 3.96, 95% CI 2.33–6.74, P<0.0001) were at high risk of developing SCI. A del/ins polymorphism of the NF-κB1 gene (OR 3.32, 95% CI 1.96–5.61, P<0.001) was also found to be associated with SCI. CONCLUSION: Our study suggests that PARP-1 polymorphisms are involved in the development of SCI in Chinese individuals. Thus, PARP-1 polymorphisms can be considered as one of the potential risk factors for developing SCI. |
format | Online Article Text |
id | pubmed-5723107 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-57231072017-12-18 Involvement of poly(ADP-ribose) polymerase-1 in development of spinal cord injury in Chinese individuals: a Chinese clinical study Meng, Qing-Tao Yang, Guang Li, Ren-Bo Nie, Jing-Xin Zhou, Wei Yu, Hong-De Chen, Bo Jiang, Li Shang, Jing-Bo Drug Des Devel Ther Original Research OBJECTIVE: We aimed to evaluate whether the polymorphism of poly(ADP-ribose) polymerase-1 (PARP-1) is involved as potential risk factor in the development of spinal cord injury (SCI) among Chinese individuals. PATIENTS AND METHODS: Patients with a confirmed diagnosis of SCI (other than traumatic injury) and healthy individuals with no clinical symptoms of SCI were enrolled at Spinal Cord Injury Care Center, The Third People’s Hospital of Dalian, China. Genetic polymorphisms were studied in plasma samples by polymerase chain reaction-restriction fragment length polymorphism assay. RESULTS: A total of 130 Chinese patients with SCI and 130 healthy Chinese individuals were included. We found that patients with the GG genotype (odds ratio [OR]: 4.09, 95% confidence interval [CI] 2.42–6.90, P<0.001) and carriers of the G allele (OR 3.96, 95% CI 2.33–6.74, P<0.0001) were at high risk of developing SCI. A del/ins polymorphism of the NF-κB1 gene (OR 3.32, 95% CI 1.96–5.61, P<0.001) was also found to be associated with SCI. CONCLUSION: Our study suggests that PARP-1 polymorphisms are involved in the development of SCI in Chinese individuals. Thus, PARP-1 polymorphisms can be considered as one of the potential risk factors for developing SCI. Dove Medical Press 2017-12-06 /pmc/articles/PMC5723107/ /pubmed/29255350 http://dx.doi.org/10.2147/DDDT.S142005 Text en © 2017 Meng et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Meng, Qing-Tao Yang, Guang Li, Ren-Bo Nie, Jing-Xin Zhou, Wei Yu, Hong-De Chen, Bo Jiang, Li Shang, Jing-Bo Involvement of poly(ADP-ribose) polymerase-1 in development of spinal cord injury in Chinese individuals: a Chinese clinical study |
title | Involvement of poly(ADP-ribose) polymerase-1 in development of spinal cord injury in Chinese individuals: a Chinese clinical study |
title_full | Involvement of poly(ADP-ribose) polymerase-1 in development of spinal cord injury in Chinese individuals: a Chinese clinical study |
title_fullStr | Involvement of poly(ADP-ribose) polymerase-1 in development of spinal cord injury in Chinese individuals: a Chinese clinical study |
title_full_unstemmed | Involvement of poly(ADP-ribose) polymerase-1 in development of spinal cord injury in Chinese individuals: a Chinese clinical study |
title_short | Involvement of poly(ADP-ribose) polymerase-1 in development of spinal cord injury in Chinese individuals: a Chinese clinical study |
title_sort | involvement of poly(adp-ribose) polymerase-1 in development of spinal cord injury in chinese individuals: a chinese clinical study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723107/ https://www.ncbi.nlm.nih.gov/pubmed/29255350 http://dx.doi.org/10.2147/DDDT.S142005 |
work_keys_str_mv | AT mengqingtao involvementofpolyadpribosepolymerase1indevelopmentofspinalcordinjuryinchineseindividualsachineseclinicalstudy AT yangguang involvementofpolyadpribosepolymerase1indevelopmentofspinalcordinjuryinchineseindividualsachineseclinicalstudy AT lirenbo involvementofpolyadpribosepolymerase1indevelopmentofspinalcordinjuryinchineseindividualsachineseclinicalstudy AT niejingxin involvementofpolyadpribosepolymerase1indevelopmentofspinalcordinjuryinchineseindividualsachineseclinicalstudy AT zhouwei involvementofpolyadpribosepolymerase1indevelopmentofspinalcordinjuryinchineseindividualsachineseclinicalstudy AT yuhongde involvementofpolyadpribosepolymerase1indevelopmentofspinalcordinjuryinchineseindividualsachineseclinicalstudy AT chenbo involvementofpolyadpribosepolymerase1indevelopmentofspinalcordinjuryinchineseindividualsachineseclinicalstudy AT jiangli involvementofpolyadpribosepolymerase1indevelopmentofspinalcordinjuryinchineseindividualsachineseclinicalstudy AT shangjingbo involvementofpolyadpribosepolymerase1indevelopmentofspinalcordinjuryinchineseindividualsachineseclinicalstudy |